can pregnant woman do rpm

Cloud DX Live in New Direct to Consumer Channel

Maternal Health Track (MHT) for pregnant women grows its reach to include 600,000 potential customers per year

News in Summary

  • Cloud DX launches new direct-to-consumer channel with access to up to 50,000 monthly e-commerce customersi
  • Maternal hypertension affects 1 in 12 pregnancies, and incidence is growingiiiii
  • Exceptionally positive reception within the high-risk pregnancy community

Cloud DX (TSXV:CDX) (OTC:CDXFF): Under the agreement executed on August 9, 2021, Cloud DX has officially launched its Maternal Health Track™ (MHT) program on e-commerce site babydoppler.com. MHT is a guided self-care program that encourages expectant mothers to monitor their blood pressure using Cloud DX Connected Health™ technology. Moms receive notifications of irregular readings, vital-sign report printouts, and direct access to Cloud DX's virtual support team

Maryland-based Neurology Technician and high-risk expectant mother Andrea León, 27, states: "As an expectant mother with a high-risk pregnancy, I am so grateful for this product. With less frequent specialist appointments in my second and third trimester, being able to monitor my vitals at home gives me so much peace of mind. As high-risk pregnant woman (and having been diagnosed as COVID), there are days where I don't feel hundred percent and it feels hard to stay on top of everything else already happening - with Maternal Health Track, it's so simple for me to check blood pressure. Managing my vitals at home puts me in control. MHT is something every high-risk pregnant woman should use."

"Since the 1990s, the prevalence of maternal hypertension has been increasing, from 5% to 8% of pregnancies today. According to Stanford University, maternal hypertension is the second leading cause of maternal deaths in the United Statesiv. That statistic could be reduced with better real-time monitoring, especially since high BP usually presents no symptoms. We want to help more moms and their babies with MHT so that they can stay on top of their vitals," says Robert Kaul, CEO and Founder at Cloud DX. "In making healthcare better for everyone, we need to ensure we bring healthy babies into this world and that starts with great maternal and prenatal care. "

With positive initial feedback and increase prevalence of maternal hypertension, Cloud DX anticipates steady sales growth into this market over the next two to three quarters, furthering its cash flow positive goal to exceed 9,000 enrolled patients across all verticals, including revenues from B2C and B2G channels.

Cloud DX's investor meeting is set for noon on December 8, 2021. You can register here. Leadership will discuss Virtual Care as a Platform and associated revenue streams, such as this direct-to-consumer channel.

Additional Information - Andrea León

As an infertility and pregnancy loss advocate, León authentically shares her story to educate others and offer advice, support, and resources. She has conceived eight times, all ending in miscarriage, and recently used IVF, PGS testing, and a high-risk protocol to ensure that her current and ninth pregnancy is successful. Her baby is due in early 2022.About Cloud DX

Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers."

Social Links:
Twitter @CloudDX
LinkedIn @Cloud-DX
Facebook @CloudDXInc
Instagram @Cloud.DX

For media inquiries contact:
Janine Scott
Marketing Lead
888-543-0944
janine.scott@CloudDX.com

For investor inquiries contact:
Jay Bedard
Investor Relations Lead
647-881-8418
jay.bedard@CloudDX.com

Footnotes

i Dagamma e-commerce site has 50,000-70,000 monthly visitors

ii Kuklina EV. Hypertension in Pregnancy in the US-One Step Closer to Better Ascertainment and Management. JAMA Netw Open. 2020;3(10):e2019364. doi:10.1001/jamanetworkopen.2020.19364

iii National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division of Behavioral and Social Sciences and Education; Board on Children, Youth, and Families; Committee on Assessing Health Outcomes by Birth Settings; Backes EP, Scrimshaw SC, editors. Birth Settings in America: Outcomes, Quality, Access, and Choice. Washington (DC): National Academies Press (US); 2020 Feb 6. 3, Epidemiology of Clinical Risks in Pregnancy and Childbirth. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555485/

iv https://stanfordhealthcare.org "Pregnancy & High Blood Pressure"

SOURCE:Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/673743/Cloud-DX-Live-in-New-Direct-to-Consumer-Channel

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less
Syntheia Rings the Opening Bell on the Canadian Securities Exchange

Syntheia Rings the Opening Bell on the Canadian Securities Exchange

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, a Canadian leader in conversational AI, is pleased to announce that the Company's leadership team rang the bell to open the market in collaboration with the Canadian Securities Exchange to celebrate its successful listing under the symbol "SYAI".

" We look forward to great success through our partnership with the CSE as we commercially launch our conversational AI to the market. On behalf of the Company, I would like to thank everyone who has made this milestone happen, " commented Tony Di Benedetto, Chief Executive Officer at Syntheia.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×